Klaus is a Partner and member of the senior leadership team at ClearView, with broad experience across the biopharmaceutical value chain. He has diverse expertise in corporate strategy and transformation, therapeutic area, disease and asset-level growth strategies as well as go-to-market and launch excellence. He led strategic engagements across a broad range of therapeutic areas, primary and specialty care. His work spans biotechs, mid-sized and large biopharmas as well as pharmacy and hospital chains.
Klaus has over 12 years of experience within life science consulting. Prior to ClearView, Klaus served as a partner at Boston Consulting Group driving the commercial strategy business.
He received his MD and Ph.D. from University of Regensburg (Germany) and gained practical experience at the Swiss Olympic Medical Center in Zurich (Switzerland). Klaus also holds a M.Sc. in Drug Research and Management from the University of Berlin, a B.Sc. in Business Administration from the University of Regensburg, and a diploma in Health Economics from European Business School Ă–strich-Winkel.
Bill Shew
David McClain
Debbi Amanti Belanger
Debbie Zhuang
Ketan Kapadia
Kevin Richard
Kim Goh
Klaus Bredl
Mike Rizzo
Philip Kenner
Richard Mynahan
Rishi Dalsania
Ryan Tubman
Sam Ulin
Seth Berman
Steven Chao
Stuart MacGregor
Jim Caruso
Sidnee Pinho
Kristine Hyde
Charles Mathews
Dave Konciak
Dean Griffiths
Jonathan Betts
Jonathan Hodgson
Mike Roy
Slater Hurst
Alec Marchuk
Alexander Lehrman
Allana Sanborn
Andrew Kang
Austin Hubbert
Beko Binder
Cem Salfati
Jessica Berard
Joanna Lee
Jonny Juliano
Kai-Ming Pu
Kelsey Yardumian
Maneesh Gujrati
Matthew Murphy
Matthew Pfister
Mike Murray
Olivia Piccione
Owen Im
Patrick Kuettner
Peter Goldman
Sarah Stapleton
Soyeon Park
Vini De Nadai
Steve Rubman
Lainey Miller